{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:24:53Z","timestamp":1793125493551,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T00:00:00Z","timestamp":1664064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T00:00:00Z","timestamp":1664064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s12325-022-02293-0","type":"journal-article","created":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T14:02:20Z","timestamp":1664114540000},"page":"5413-5432","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Risk of Severe COVID-19 Outcomes Among Patients with Immune-Mediated Inflammatory Diseases or Malignancies: A Retrospective Analysis of Real-World Data in the United States"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4418-7079","authenticated-orcid":false,"given":"Xiaomeng","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9090-9431","authenticated-orcid":false,"given":"Yizhou","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yookyung C.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4421-7183","authenticated-orcid":false,"given":"Dongmu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1868-4300","authenticated-orcid":false,"given":"Whitney S.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,25]]},"reference":[{"key":"2293_CR1","unstructured":"WHO Director-General\u2019s remarks at the media briefing on 2019-nCoV on 11 February 2020. https:\/\/www.who.int\/dg\/speeches\/detail\/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020."},{"key":"2293_CR2","unstructured":"WHO coronavirus disease (COVID-19) Dashboard. https:\/\/covid19.who.int\/."},{"key":"2293_CR3","unstructured":"United States COVID-19 cases, deaths, and laboratory testing (NAATs) by state, territory, and jurisdiction. https:\/\/covid.cdc.gov\/covid-data-tracker\/#cases-deaths-testing-trends. Accessed 8 Mar 2022."},{"issue":"2","key":"2293_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1001\/jama.2020.24865","volume":"325","author":"SH Woolf","year":"2021","unstructured":"Woolf SH, Chapman DA, Lee JH. COVID-19 as the leading cause of death in the United States. JAMA. 2021;325(2):123\u20134.","journal-title":"JAMA"},{"key":"2293_CR5","doi-asserted-by":"crossref","unstructured":"Kitsis RN, Riquelme JA, Lavandero S. Heart disease and cancer: are the two killers colluding? Circulation. 2018;138:692\u20135.","DOI":"10.1161\/CIRCULATIONAHA.118.033907"},{"issue":"4","key":"2293_CR6","first-page":"207","volume":"60","author":"E Giovannucci","year":"2010","unstructured":"Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report. CA: Cancer J Clin. 2010;60(4):207\u201321.","journal-title":"CA: Cancer J Clin"},{"issue":"3","key":"2293_CR7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<653::AID-CNCR24>3.0.CO;2-1","volume":"88","author":"KS Ogle","year":"2000","unstructured":"Ogle KS, Swanson GM, Woods N, Azzouz F. Cancer and comorbidity: redefining chronic diseases. Cancer. 2000;88(3):653\u201363.","journal-title":"Cancer"},{"issue":"6024","key":"2293_CR8","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1126\/science.1203486","volume":"331","author":"RD Schreiber","year":"2011","unstructured":"Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion. Science. 2011;331(6024):1565\u201370.","journal-title":"Science"},{"key":"2293_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab250","author":"EH Tan","year":"2021","unstructured":"Tan EH, Sena AG, Prats-Uribe A, et al. COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries. Rheumatology. 2021. https:\/\/doi.org\/10.1093\/rheumatology\/keab250.","journal-title":"Rheumatology"},{"issue":"5","key":"2293_CR10","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.2337\/dc10-1756","volume":"34","author":"TM Triolo","year":"2011","unstructured":"Triolo TM, Armstrong TK, McFann K, et al. Additional autoimmune disease found in 33% of patients at type 1 diabetes onset. Diabetes Care. 2011;34(5):1211\u20133.","journal-title":"Diabetes Care"},{"issue":"2","key":"2293_CR11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1001\/jamaoncol.2020.6178","volume":"7","author":"Q Wang","year":"2021","unstructured":"Wang Q, Berger NA, Xu R. Analyses of risk, racial disparity, and outcomes among US patients with cancer and COVID-19 infection. JAMA Oncol. 2021;7(2):220\u20137.","journal-title":"JAMA Oncol"},{"issue":"9","key":"2293_CR12","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1136\/annrheumdis-2020-217888","volume":"79","author":"KM D\u2019Silva","year":"2020","unstructured":"D\u2019Silva KM, Serling-Boyd N, Wallwork R, et al. Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US \u2018hot spot.\u2019 Ann Rheum Dis. 2020;79(9):1156\u201362.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2293_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/acr2.11221","volume":"3","author":"RC Ungaro","year":"2021","unstructured":"Ungaro RC, Agrawal M, Park S, et al. Autoimmune and chronic inflammatory disease patients with COVID-19. ACR Open Rheumatol. 2021;3(2):111\u20135.","journal-title":"ACR Open Rheumatol"},{"key":"2293_CR14","unstructured":"MacKenna B, Kennedy NA, Mehrkar A, et al. Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform. Lancet Rheumatol. 2022;4(7):e490\u2013e506."},{"issue":"3","key":"2293_CR15","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3899\/jrheum.200989","volume":"48","author":"AS Faye","year":"2021","unstructured":"Faye AS, Lee KE, Laszkowska M, et al. Risk of adverse outcomes in hospitalized patients with autoimmune disease and COVID-19: a matched cohort study from New York City. J Rheumatol. 2021;48(3):454\u201362.","journal-title":"J Rheumatol"},{"issue":"10241","key":"2293_CR16","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/S0140-6736(20)31187-9","volume":"395","author":"NM Kuderer","year":"2020","unstructured":"Kuderer NM, Choueiri TK, Shah DP, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395(10241):1907\u201318.","journal-title":"Lancet"},{"issue":"3","key":"2293_CR17","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/j.jinf.2020.05.065","volume":"81","author":"M Liu","year":"2020","unstructured":"Liu M, Gao Y, Zhang Y, Shi S, Chen Y, Tian J. The association between severe or dead COVID-19 and autoimmune diseases: a systematic review and meta-analysis. J Infect. 2020;81(3):e93\u20135.","journal-title":"J Infect"},{"key":"2293_CR18","unstructured":"Optum, Inc. Optum EHR data. https:\/\/www.optum.com\/business\/solutions\/life-sciences\/real-world-data\/ehr-data.html."},{"key":"2293_CR19","unstructured":"Centers for Disease Control and Prevention. ICD-10-CM official coding and reporting guidelines: April 1, 2020 through September 30, 2020. https:\/\/www.cdc.gov\/nchs\/icd\/icd10cm.htm."},{"key":"2293_CR20","unstructured":"Human infection with 2019 novel coronavirus case report form. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/downloads\/pui-form.pdf."},{"issue":"1","key":"2293_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-11-83","volume":"11","author":"SK Thygesen","year":"2011","unstructured":"Thygesen SK, Christiansen CF, Christensen S, Lash TL, S\u00f8rensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol. 2011;11(1):1\u20136.","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"2293_CR22","first-page":"188","volume":"12","author":"WP Glasheen","year":"2019","unstructured":"Glasheen WP, Cordier T, Gumpina R, Haugh G, Davis J, Renda A. Charlson comorbidity index: ICD-9 update and ICD-10 translation. Am Health Drug Benefits. 2019;12(4):188.","journal-title":"Am Health Drug Benefits"},{"key":"2293_CR23","unstructured":"The U.S. Census Bureau. Age and Sex Composition in the United States: 2010. https:\/\/www.census.gov\/data\/tables\/2010\/demo\/age-and-sex\/2010-age-sex-composition.html."},{"issue":"25","key":"2293_CR24","doi-asserted-by":"publisher","first-page":"922","DOI":"10.15585\/mmwr.mm7025e1","volume":"70","author":"J Diesel","year":"2021","unstructured":"Diesel J, Sterrett N, Dasgupta S, et al. COVID-19 vaccination coverage among adults\u2014United States, December 14, 2020\u2013May 22, 2021. Morb Mortal Wkly Rep. 2021;70(25):922.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"2","key":"2293_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41584-020-00562-2","volume":"17","author":"KL Hyrich","year":"2021","unstructured":"Hyrich KL, Machado PM. Rheumatic disease and COVID-19: epidemiology and outcomes. Nat Rev Rheumatol. 2021;17(2):71\u20132.","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"2293_CR26","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1002\/art.41800","volume":"73","author":"BR England","year":"2021","unstructured":"England BR, Roul P, Yang Y, et al. Risk of COVID-19 in rheumatoid arthritis: a national veterans affairs matched cohort study in at-risk individuals. Arthritis Rheumatol. 2021;73(12):2179\u201388.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"2293_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1056\/NEJMc2009567","volume":"383","author":"R Haberman","year":"2020","unstructured":"Haberman R, Axelrad J, Chen A, et al. Covid-19 in immune-mediated inflammatory diseases\u2014case series from New York. N Engl J Med. 2020;383(1):85\u20138.","journal-title":"N Engl J Med"},{"issue":"3","key":"2293_CR28","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","volume":"21","author":"W Liang","year":"2020","unstructured":"Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335\u20137.","journal-title":"Lancet Oncol"},{"key":"2293_CR29","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.semarthrit.2021.08.010","volume":"51","author":"R Raiker","year":"2021","unstructured":"Raiker R, DeYoung C, Pakhchanian H, et al. Outcomes of COVID-19 in patients with rheumatoid arthritis: a multicenter research network study in the United States. Semin Arthritis Rheum. 2021;51:1057\u201366.","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"2293_CR30","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1136\/gutjnl-2020-321411","volume":"69","author":"C Bezzio","year":"2020","unstructured":"Bezzio C, Saibeni S, Variola A, et al. Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study. Gut. 2020;69(7):1213\u20137.","journal-title":"Gut"},{"issue":"2","key":"2293_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/ueg2.12049","volume":"9","author":"JF Ludvigsson","year":"2021","unstructured":"Ludvigsson JF, Axelrad J, Halfvarson J, et al. Inflammatory bowel disease and risk of severe COVID-19: a nationwide population-based cohort study in Sweden. UEG J. 2021;9(2):177\u201392.","journal-title":"UEG J"},{"issue":"4","key":"2293_CR32","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1053\/j.gastro.2020.06.003","volume":"159","author":"S Singh","year":"2020","unstructured":"Singh S, Khan A, Chowdhry M, Bilal M, Kochhar GS, Clarke K. Risk of severe coronavirus disease 2019 in patients with inflammatory bowel disease in the United States: a multicenter research network study. Gastroenterology. 2020;159(4):1575-1578. e1574.","journal-title":"Gastroenterology"},{"key":"2293_CR33","doi-asserted-by":"crossref","unstructured":"Nguyen C, Yale K, Casale F, et al. SARS-CoV-2 infection in patients with atopic dermatitis: a cross-sectional study. Br J Dermatol. 2021;185(3):640\u20131.","DOI":"10.1111\/bjd.20435"},{"issue":"4","key":"2293_CR34","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jaci.2020.08.008","volume":"146","author":"JM Yang","year":"2020","unstructured":"Yang JM, Koh HY, Moon SY, et al. Allergic disorders and susceptibility to and severity of COVID-19: a nationwide cohort study. J Allergy Clin Immunol. 2020;146(4):790\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"2293_CR35","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.anai.2020.07.012","volume":"125","author":"A Keswani","year":"2020","unstructured":"Keswani A, Dhana K, Rosenthal JA, Moore D, Mahdavinia M. Atopy is predictive of a decreased need for hospitalization for coronavirus disease 2019. Ann Allergy Asthma Immunol. 2020;125(4):479.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"2293_CR36","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3899\/jrheum.210888","volume":"49","author":"JR Curtis","year":"2022","unstructured":"Curtis JR, Zhou X, Rubin DT, et al. Characteristics, comorbidities, and outcomes of SARS-CoV-2 infection in patients with autoimmune conditions treated with systemic therapies: a population-based study. J Rheumatol. 2022;49(3):320\u20139.","journal-title":"J Rheumatol"},{"issue":"7","key":"2293_CR37","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1046\/j.1365-2230.2000.00698.x","volume":"25","author":"HC Williams","year":"2000","unstructured":"Williams HC. Epidemiology of atopic dermatitis. Clin Exp Dermatol. 2000;25(7):522\u20139.","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"2293_CR38","doi-asserted-by":"publisher","first-page":"A386","DOI":"10.1016\/j.autrev.2011.11.012","volume":"11","author":"L Moroni","year":"2012","unstructured":"Moroni L, Bianchi I, Lleo A. Geoepidemiology, gender and autoimmune disease. Autoimmun Rev. 2012;11(6):A386\u201392.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"2293_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247461","volume":"16","author":"A Booth","year":"2021","unstructured":"Booth A, Reed AB, Ponzo S, et al. Population risk factors for severe disease and mortality in COVID-19: a global systematic review and meta-analysis. PLoS ONE. 2021;16(3): e0247461.","journal-title":"PLoS ONE"},{"key":"2293_CR40","doi-asserted-by":"crossref","unstructured":"Barber MR, Drenkard C, Falasinnu T, et al. Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17(9):515\u201332.","DOI":"10.1038\/s41584-021-00668-1"},{"issue":"9","key":"2293_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003321","volume":"17","author":"SL Harrison","year":"2020","unstructured":"Harrison SL, Fazio-Eynullayeva E, Lane DA, Underhill P, Lip GY. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: a federated electronic medical record analysis. PLoS Med. 2020;17(9): e1003321.","journal-title":"PLoS Med"},{"issue":"2","key":"2293_CR42","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1016\/j.jinf.2020.04.021","volume":"81","author":"Z Zheng","year":"2020","unstructured":"Zheng Z, Peng F, Xu B, et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81(2):e16\u201325.","journal-title":"J Infect"},{"key":"2293_CR43","doi-asserted-by":"crossref","unstructured":"Ko JY, Danielson ML, Town M, et al. Risk factors for COVID-19-associated hospitalization: COVID-19-associated hospitalization surveillance network and behavioral risk factor surveillance system. Clin Infect Dis. 2021;72(11):e695\u2013e703.","DOI":"10.1093\/cid\/ciaa1419"},{"issue":"3","key":"2293_CR44","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/jamainternmed.2020.5313","volume":"181","author":"JW Cunningham","year":"2021","unstructured":"Cunningham JW, Vaduganathan M, Claggett BL, et al. Clinical outcomes in young US adults hospitalized with COVID-19. JAMA Intern Med. 2021;181(3):379\u201381.","journal-title":"JAMA Intern Med"},{"key":"2293_CR45","doi-asserted-by":"crossref","unstructured":"Kuswardhani RT, Henrina J, Pranata R, Lim MA, Lawrensia S, Suastika K. Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: a systematic review and meta-analysis. Diabetes Metab Syndr. 2020;14(6):2103\u20139.","DOI":"10.1016\/j.dsx.2020.10.022"},{"issue":"20","key":"2293_CR46","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1001\/jama.2021.19499","volume":"326","author":"MW Tenforde","year":"2021","unstructured":"Tenforde MW, Self WH, Adams K, et al. Association between mRNA vaccination and COVID-19 hospitalization and disease severity. JAMA. 2021;326(20):2043\u201354.","journal-title":"JAMA"},{"issue":"20","key":"2293_CR47","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1001\/jama.2021.19063","volume":"326","author":"M Klompas","year":"2021","unstructured":"Klompas M. Understanding breakthrough infections following mRNA SARS-CoV-2 vaccination. JAMA. 2021;326(20):2018\u201320.","journal-title":"JAMA"},{"key":"2293_CR48","unstructured":"FDA takes additional action in fight against COVID-19 by issuing Emergency Use Authorization for second COVID-19 vaccine. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-takes-additional-action-fight-against-covid-19-issuing-emergency-use-authorization-second-covid."},{"key":"2293_CR49","unstructured":"COVID-19 Vaccinations in the United States, Jurisdiction. https:\/\/data.cdc.gov\/Vaccinations\/COVID-19-Vaccinations-in-the-United-States-Jurisdi\/unsk-b7fc."},{"key":"2293_CR50","unstructured":"Centers for Disease Control and Prevention. Cumulative count of fully vaccinated people reported to CDC by date administered, United States. https:\/\/covid.cdc.gov\/covid-data-tracker\/#vaccination-trends_vacctrends-fully-cum."},{"key":"2293_CR51","doi-asserted-by":"publisher","unstructured":"Mainous AG 3rd, Rooks BJ, Wu V, Orlando FA. COVID-19 post-acute sequelae among adults: 12 month mortality risk. Front Med. 2021;2351. https:\/\/doi.org\/10.3389\/fmed.2021.778434.","DOI":"10.3389\/fmed.2021.778434"},{"issue":"12","key":"2293_CR52","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1136\/annrheumdis-2020-218296","volume":"79","author":"JL Pablos","year":"2020","unstructured":"Pablos JL, Galindo M, Carmona L, et al. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study. Ann Rheum Dis. 2020;79(12):1544\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"2293_CR53","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","volume":"79","author":"M Gianfrancesco","year":"2020","unstructured":"Gianfrancesco M, Hyrich KL, Al-Adely S, et al. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2020;79(7):859\u201366.","journal-title":"Ann Rheum Dis"},{"key":"2293_CR54","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-eular.565","author":"Y Ye","year":"2021","unstructured":"Ye Y, Yue X, Krueger W, Wegrzyn L. POS1163 characteristics and outcomes in a real-world cohort of rheumatoid arthritis patients with COVID-19. Ann Rheum Dis. 2021. https:\/\/doi.org\/10.1136\/annrheumdis-2021-eular.565.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"2293_CR55","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/nrrheum.2010.86","volume":"6","author":"Y Shapira","year":"2010","unstructured":"Shapira Y, Agmon-Levin N, Shoenfeld Y. Geoepidemiology of autoimmune rheumatic diseases. Nat Rev Rheumatol. 2010;6(8):468\u201376.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"2293_CR56","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jaut.2008.08.004","volume":"31","author":"Y Shoenfeld","year":"2008","unstructured":"Shoenfeld Y, Selmi C, Zimlichman E, Gershwin ME. The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun. 2008;31(4):325\u201330.","journal-title":"J Autoimmun"},{"key":"2293_CR57","unstructured":"McDermott D, Cox C, Rudowitz R, Garfield R. How has the pandemic affected health coverage in the U.S.? San Francisco: Kaiser Family Foundation; 2020."}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02293-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-022-02293-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02293-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T16:19:26Z","timestamp":1667146766000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-022-02293-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,25]]},"references-count":57,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2293"],"URL":"https:\/\/doi.org\/10.1007\/s12325-022-02293-0","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,25]]},"assertion":[{"value":"13 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}